| Top 50 Most Viewed Posts Last Week |
|---|
|
Today This Week Last Week This Month Last Month
|
1. sherlock57: I read somewhere--probably one of the PRs--that (1606)  (20) |
| 2. KenChowder: Misiu asked me to post the one-year numbers for (1449) (15) |
| 3. My69z: 3 yrs ago -- ICI Agreement with major institution (1417) (8) |
| 4. Enjay: Dr. Pestell was co-author of a report entitled (806) (10) |
| 5. chazzledazzle: From Cytosphere on Reddit. San Antonio Breast (790) (16) |
| 6. Katangolo: Man, you’ve been through this. Long enough to (762) (14) |
| 7. MJS719: Possibly another cancer that leronlimab can turn (744) |
| 8. docj: CytoDyn to Present Prolonged Survival Data on (687) (13) |
| 9. KenChowder: Here's my favorite part of the new interview from (671) (22) |
| 10. Enjay: Chazzledazzle posted the abstract for the (665) (19) |
| 11. skezan: From LinkedIn: Experience Logo of CytoDyn CytoDyn (653) (1) |
| 12. DJknows: Presenter: Dr. Milana V. Dolezal, MD, MSci, (648) (8) |
| 13. Shelly2626: Exactly I'm waiting for the big news and have (628) (5) |
| 14. Evil Rabbit: Hopefully the thieves let it spike up a bit (628) (12) |
| 15. sherlock57: Merck? Really??? Even though they are in three (621) (15) |
| 16. cardamine: I'll take that close - esp with the volume. (619) (4) |
| 17. mountaineer: Does not appear that will happen unfortunately. (613) (1) |
| 18. KenChowder: Nice, Sherlock. Re: trials we'd personally like (609) (12) |
| 19. KenChowder: This just in from our Somebody-Knows-Something (609) (7) |
| 20. twinter11: I saw that EAP a few days ago and posted it on (597) (5) |
| 21. sherlock57: On the ESMO TNBC poster, on the lower left, is (584) (4) |
| 22. docj: Have a family member who has been on the sideline (582) (10) |
| 23. Boatbuilder: Does Dr. Dolezal have a previous affiliation with (581) (5) |
| 24. Figgs: I feel we are more looking for a partnership more (568) (4) |
| 25. twinter11: Here's some if what I think happened with the 12. (560) (3) |
| 26. Figgs: NYTimes says Caroline Kennedy's daughter, Tatiana (560) |
| 27. twinter11: I reread these the other day in the 2025 Sept (556) (3) |
| 28. skezan: "Sixteen patients showed a drop in CAMLs/CTCs (551) (1) |
| 29. Boatbuilder: On a buy order? Fidelity does the same thing to (550) (1) |
| 30. MJS719: I’m getting a never before seen message when I (535) |
| 31. cardamine: hmmm well will be interesting to figure (530) |
| 32. twinter11: Targeting WEE1 Kinase for Breast Cancer (527) (18) |
| 33. Mr3Putt: Guessing: Look for updates in a year end (526) (3) |
| 34. MGK_2: So, in the experiment, they took 4 monkeys (525) (14) |
| 35. twinter11: i dont think so. heres what i put on livimmune a (524) (3) |
| 36. cardamine: Cytodyn's emphasis on publicizing the safety (522) (10) |
| 37. Figgs: Does anyone know when our FDA meeting is? Also (521) |
| 38. MJS719: Just a limit. I’ve not changed anything from (516) (1) |
| 39. twinter11: I recently saw some linkedin profile that (515) (1) |
| 40. twinter11: Where did you see 5 were upgraded to 525? In the (513) |
| 41. seemingly-harmless: pile in!! i'll save a seat for (510) (3) |
| 42. twinter11: Its almost impossible to get anyone past the (507) (3) |
| 43. mountaineer: 100% agree...as excited as we get when it reaches (502) |
| 44. twinter11: I agree with all that. I said the other day Not (502) (1) |
| 45. dfwl28: Stanford and Cydodyn! Perfect together. Close at (500) |
| 46. twinter11: Heres an example of the issue I have Here is a (494) (3) |
| 47. SamaGong: By definition, medical malpractice involves a (491) (2) |
| 48. mountaineer: Well it was a nice run up today. Still green but (489) (1) |
| 49. DJknows: Why indeed... can't be sure of anything but she (487) (1) |
| 50. mountaineer: Fidelity does not show that. Did you hit "margin" (487) |
